These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1374792)

  • 41. Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics.
    Hibbeln JR; Linnoila M; Umhau JC; Rawlings R; George DT; Salem N
    Biol Psychiatry; 1998 Aug; 44(4):235-42. PubMed ID: 9715354
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interactions between central monoaminergic systems: dopamine-serotonin.
    Roccatagliata G; Albano C; Cocito L; Maffini M
    J Neurol Neurosurg Psychiatry; 1979 Dec; 42(12):1159-62. PubMed ID: 160445
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dopamine and serotonin metabolism in hepatic encephalopathy.
    Knell AJ; Davidson AR; Williams R; Kantamaneni BD; Curzon G
    Br Med J; 1974 Mar; 1(5907):549-51. PubMed ID: 4817189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serotonin (5HT) systems in psychotic states.
    Bowers MB
    Psychopharmacol Commun; 1975; 1(6):655-62. PubMed ID: 1224018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interacting neurotransmitter systems. A non-experimental approach to the 5HIAA-HVA correlation in human CSF.
    Agren H; Mefford IN; Rudorfer MV; Linnoila M; Potter WZ
    J Psychiatr Res; 1986; 20(3):175-93. PubMed ID: 2430098
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MMPI measures of impulsivity and depression correlate with CSF 5-HIAA and HVA in depression but not schizophrenia.
    Faustman WO; King RJ; Faull KF; Moses JA; Benson KL; Zarcone VP; Csernansky JG
    J Affect Disord; 1991 Aug; 22(4):235-9. PubMed ID: 1939932
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Determination of HVA and 5-HIAA in epileptic syndromes in basal conditions and after treatment with probenecid].
    Carrieri P; Orefice G; Mandarini A; Rossi V; Campanella G
    Acta Neurol Quad (Napoli); 1979; 39():42-7. PubMed ID: 95499
    [No Abstract]   [Full Text] [Related]  

  • 48. 5-HIAA in cerebrospinal fluid and deficit schizophrenic characteristics.
    Csernansky JG; King RJ; Faustman WO; Moses JA; Poscher ME; Faull KF
    Br J Psychiatry; 1990 Apr; 156():501-7. PubMed ID: 1696842
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function.
    Kahn RS; Harvey PD; Davidson M; Keefe RS; Apter S; Neale JM; Mohs RC; Davis KL
    Schizophr Res; 1994 Feb; 11(3):217-24. PubMed ID: 7514887
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Test-retest stability of the oral niacin test and electrodermal activity in patients with schizophrenia.
    Nilsson BM; Hultman CM; Ekselius L
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(5-6):367-72. PubMed ID: 19864122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dopamine turnover in schizophrenia before and after haloperidol withdrawal. CSF, plasma, and urine studies.
    Beuger M; van Kammen DP; Kelley ME; Yao J
    Neuropsychopharmacology; 1996 Jul; 15(1):75-86. PubMed ID: 8797194
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The cardiac responses of schizophrenics to orienting, signal and non-signal tones.
    Gruzelier JH
    Biol Psychol; 1975 Sep; 3(2):143-55. PubMed ID: 1225368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does dantrolene influence central dopamine and serotonin metabolism in the neuroleptic malignant syndrome? A retrospective study.
    Nisijima K; Ishiguro T
    Biol Psychiatry; 1993 Jan; 33(1):45-8. PubMed ID: 7678377
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Disorders of dopamine and 5-hydroxytryptamine metabolism in the early period after cranio-cerebral injuries].
    Majchrzak H; Kmieciak-KoĊ‚ada K; Herman Z
    Neurol Neurochir Pol; 1979; 13(3):289-93. PubMed ID: 471161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electrodermal and vascular orienting response in schizophrenic patients: relationship to symptoms and medication.
    Schlenker R; Cohen R; Hubmann W; Mohr F; Wahlheim C; Watzl H; Werther P
    Eur Arch Psychiatry Clin Neurosci; 1995; 245(3):152-8. PubMed ID: 7669822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Schizophrenia, psychosis, and cerebral spinal fluid homovanillic acid concentrations.
    Maas JW; Bowden CL; Miller AL; Javors MA; Funderburg LG; Berman N; Weintraub ST
    Schizophr Bull; 1997; 23(1):147-54. PubMed ID: 9050120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alcohol and central serotonin metabolism in man.
    Ballenger JC; Goodwin FK; Major LF; Brown GL
    Arch Gen Psychiatry; 1979 Feb; 36(2):224-7. PubMed ID: 420544
    [TBL] [Abstract][Full Text] [Related]  

  • 58. What does electrodermal activity tell us about prognosis in the schizophrenia spectrum?
    Dawson ME; Schell AM
    Schizophr Res; 2002 Mar; 54(1-2):87-93. PubMed ID: 11853982
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Altered serotonin activity in anorexia nervosa after long-term weight restoration. Does elevated cerebrospinal fluid 5-hydroxyindoleacetic acid level correlate with rigid and obsessive behavior?
    Kaye WH; Gwirtsman HE; George DT; Ebert MH
    Arch Gen Psychiatry; 1991 Jun; 48(6):556-62. PubMed ID: 1710099
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structure-function relations in schizophrenia: brain morphology and neuropsychology.
    Bilder RM
    Prog Exp Pers Psychopathol Res; 1992; 15():183-251. PubMed ID: 1285281
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.